Regeneron Pharmaceuticals, Inc.

REGN.VI·Vienna·Healthcare
Compare
830.80−22.90 (−2.68%)today
As of Nov 5, 11:00 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close853.70
Open829.80
Day range829.80830.80
52-week range512.70876.70
Off day high0.00%
Off 52-week high−5.24%
Volume0.00
Avg. volume (3M)0.00
Market cap85.94B
EPS (TTM)38.94
Forward P/E—
P/E ratio (TTM)21.34
Dividend yield0.39% (3.36)
Beta (5Y)0.10
Shares outstanding101.63M
Short interest—
Earnings dateOct 30, 2026 (est.)
Analyst target—
Profit margin28.51%

Against its peers

Compare in full ›
REGN.VI 9995.HK ROIV 4593.T RPRX 214450.KQ
Market cap 85.94B 40.23B 27.61B 33.08B 39.04B 2.34T
P/E (TTM) 21.3 6.1 — 235.6 44.2 —
Forward P/E — 46.7 -27.5 -8.6 11.6 —
Price/book 2.8 3.8 6.5 3.8 4.5 —
Dividend yield 0.39% — — — 1.39% 1.66%
1-year change +50.56% −19.94% +85.85% −46.41% +64.28% −56.00%
Today −2.68% +1.49% +6.08% −3.54% +1.75% +0.67%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Regeneron Pharmaceuticals's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
RemeGen Co., Ltd.9995.HK · Biotechnology 40.23B 71.300 +1.49%
Roivant Sciences Ltd.ROIV · Biotechnology 27.61B 38.23 +6.08%
Healios K.K.4593.T · Biotechnology 33.08B 245.00 −3.54%
Royalty Pharma plcRPRX · Biotechnology 39.04B 67.56 +1.75%
PharmaResearch Co., Ltd.214450.KQ · Biotechnology 2.34T 225,000.00 +0.67%
BrightGene Bio-Medical Technology Co., Ltd.688166.SS · Biotechnology 13.81B 31.70 +2.42%
Biocon LimitedBIOCON.NS · Biotechnology 592.87B 362.00 +5.10%
Krystal Biotech, Inc.KRYS · Biotechnology 9.21B 310.84 +1.90%

Also based in Tarrytown, New York, then elsewhere in New York.

Company Mkt cap Price Today
Prestige Consumer Healthcare Inc.PBH · Tarrytown, NY 2.52B 53.28 +7.55%
Citigroup Inc.C.BA · New York, NY 347.10T 69,900.00 +2.38%
Coinbase Global, Inc.COIN.BA · New York, NY 67.45T 9,435.00 +4.43%
The Bank of New York Mellon CorporationBNY.BA · New York, NY 43.07T 128,000.00 +2.58%
Verizon Communications Inc.VZ.BA · New York, NY 39.54T 19,080.00 +1.27%
Pfizer Inc.PFE.BA · New York, NY 36.68T 12,870.00 +2.63%
JPMorgan Chase & Co.JPM · New York, NYOdds 935.07B 352.11 +4.18%
Colgate-Palmolive CompanyCL.BA · New York, NY 14.28T 53,900.00 +1.60%

The stocks whose daily moves over the past year went most closely with Regeneron Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Regeneron Pharmaceuticals, Inc.0R2M.L · Correlation 0.86 — 932.00 −1.80%
Regeneron Pharmaceuticals, Inc.REGN34.SA · Correlation 0.68 531.93B 85.70 −3.73%
Regeneron Pharmaceuticals, Inc.RGO.F · Correlation 0.62 85.86B 830.00 −1.44%
Vertex Pharmaceuticals IncorporatedVRTX.VI · Correlation 0.41 124.39B 490.75 +1.73%
Sanofi1SAN.MI · Correlation 0.34 84.87B 70.84 −3.28%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All REGN.VI news ›
Trefis·

Is Regeneron Stock Increasing Your Market Risk?

If you hold Regeneron Pharmaceuticals (REGN) or plan to, its 19.0% rise from October 26 to November 2, 2026, while the S&P 500 fell 1.8%, likely caught your eye. Your other money probably already follows the market, so how Regeneron…

REGNSNY
Trefis·Positive

Was There Any Sign Regeneron Stock Would Run?

An investor who bought a $10,000 stake in Regeneron Pharmaceuticals (REGN) at the October 31, 2025 close held about $15,010 on November 3, 2026. The company’s sales growth picked up over those twelve months. Management says most of the…

REGNSNY
JournalArta·Positive

REGN Stock Gains 3.60%, RSI Overbought In Focus

JournalArta REGN Stock Gains 3.60%, RSI Overbought In Focus On November 2, 2026: price 961.26 USD, trend uptrend, RSI 81.9, support 738.72, resistance 961.26. technical analysis of regn stock. REGN Stock Gains — full… Why REGN is in focus…

REGN
european-biotechnology.com·Positive

Beyond monoclonals: Multispecific antibodies

New biologic logic – Multispecific antibodies extend targeted therapy beyond one antigen or pathway. By combining binding sites, cell recruitment and defined valencies within one molecule, they enable mechanisms that conventional…

REGNTWSTSNY

From the 4Search news index, newest first.

In the news

315mentions in 30 days
82with it in the headline
Positivesentiment

Mentioned with

Regeneron294Regeneron Pharmaceuticals, Inc.247Regeneron Pharmaceuticals, Inc244Sanofi221Hagens Berman Sobol Shapiro Llp118TD Cowen93Regeneron-Sanofi Alliance90Alliance78

People in the coverage

Yancopoulos172Libtayo167Benzinga125Dupixent124Hagens Berman123Reed Kathrein120

Themes

Healthcare126Il-1377PR Newswire76Sny75Sanofi7375886F1071Biotechnology67Finanzen67

Most coverage from

  1. marketscreener.com62
  2. tradingview.com23
  3. marketbeat.com21
  4. seekingalpha.com19
  5. markets.businessinsider.com15

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance